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aBstraCt
introduCtion. The aim of the study is to determine which depicting modality, fundus autofluorescence or mul-
ticolour imaging, is a better diagnostic tool in the monitoring of the progression of geographic atrophy in patients 
with severe dry macular degeneration.
MateriaL and Methods. Fifty patients (93 eyes) participated in this study. OCT examination (Spectralis HRA + 
OCT, Heidelberg Engineering, Germany) was performed in order to confirm that they fit the criteria to proceed in 
the study. In all patients, fundus autofluorescence and multicolour imaging was performed.
resuLts. The area of geographic atrophy was depicted with both modalities and useful information was obtained. In 
some cases, multicolour imaging provided more useful clues and in other cases the fundus autofluorescence provided 
useful information for the progression of the disease.
ConCLusions. Both modalities provide a wide range of useful information about the progression of geographic 
atrophy in patients with severe dry age-related macular degeneration and should both be performed in order to 
gather all the useful information about the disease progression.
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introduCtion
Age-related macular degeneration (AMD) is an 
acquired degeneration of the retina that causes sig-
nificant central visual impairment [1, 2]. AMD is 
the most common cause of irreversible vision loss 
in the developed world. The disease manifests with 
two types: the non-neovascular or dry type, which 
includes the formation of drusen and retinal pig-
ment epithelium abnormalities, and or wet type, 
which includes a choroidal neovascular membrane 
formation [1–3]. Approximately 85% to 90% of 
the cases of macular degeneration are dry type. Dry, 
age-related macular degeneration does not involve 
any leakage of blood or serum.
Drusen are small white or yellowish deposits that 
form under the retina [4, 5], beneath the macula, 
causing it to deteriorate or degenerate over time. 
These small yellow deposits [6, 7] beneath the retina 
are a build-up of metabolic waste materials. They are 
made up of cholesterol, protein, and fats. Typically, 
when they first form, they do not cause any vision 
loss. However, they are a risk factor for progression 
to vision loss. These small yellowish deposits be-
come larger as the disease progresses. As dry AMD 
progresses [8] to retinal atrophy and central retinal 
degeneration, loss of central vision is often observed. 
Nearly all people over the age of 50 years have 
at least one small drusen in one or both eyes [9]. 
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Generally, dry AMD has a much slower, progressive 
visual loss relative to wet AMD.
No one knows exactly what causes macular de-
generation. However, several studies [10] indicate 
it may be related to a  combination of hereditary 
and environmental factors, including smoking and 
diet. There are also studies indicating that people of 
European ancestry and lighter eye colour may face 
a greater risk for AMD.
Dry macular degeneration symptoms usually 
develop gradually [11]. They may include: visual 
distortions, such as straight lines seeming bent, re-
duced central vision in one or both eyes, increased 
blurriness of printed words, the need for brighter 
light when reading or doing close work, increased 
difficulty adapting to low light levels, decreased in-
tensity or brightness of colours, and difficulty rec-
ognising faces.
Funduscopically [11], in early to intermediate 
dry AMD there is significant presence of multiple 
drusen. In intermediate dry AMD, drusen may ap-
pear confluent with significant pigment changes 
and pigment accumulation in the posterior pole. 
In addition, the retinal pigment epithelium (RPE) 
often appears atrophic, with easier visualisation of 
the underlying choroid vascular plexus. In advanced 
stages of dry AMD, there is coalescence of focal 
islands of atrophy and formation of large zones 
of atrophy that severely affect vision. Geographic 
atrophy (GA) is a chronic progressive degeneration 
of the macula as part of the late stage of dry AMD. 
The disease is characterised by localised atrophy of 
retinal tissue and choriocapillaris leading to central 
scotomas and permanent loss of visual acuity. 
In patients diagnosed with AMD, an Amsler grid [12] 
should be used, in order to check on a weekly ba-
sis if they observe any changes on it, so as to seek 
professional opinion if they do. The progress of the 
disease should also be closely monitored by an oph-
thalmologist every 3–6 months. Optical coherence 
tomography (OCT) [13] can be used in order to 
observe the progress of the disease. Also, a  fluo-
rescein angiography may be performed when the 
disease has recently been diagnosed or the patient 
experiences sudden vision deterioration, in order to 
check if a vessel leakage has occurred and therefore 
the disease has progressed into wet AMD type.
Studies suggest that eating antioxidant-rich 
foods [14], such as fresh fruits and dark green leafy 
vegetables (such as kale, collard greens, and spin-
ach), may delay the onset or reduce the severity of 
dry AMD. These types of vegetables contain lutein, 
which may protect the macula from sun damage, 
just as it protects the leaves of the vegetables from 
sun damage. Also, eating at least one serving of fatty 
fish per week may also delay the onset or reduce the 
severity of dry AMD. These types of fish are high 
in omega-3 fatty acids, which help decrease inflam-
mation and promote eye health. Regular exercise 
also has many known health benefits. By exercising 
frequently, the danger of obesity, which can be as-
sociated with the appearance of AMD, diminish-
es. Using absorbent sunglasses is also a detrimental 
precaution to maintain eye health.
Fundus autofluorescence (FAF) [15–17] is 
a  noninvasive imaging technology that gives in-
formation on the distribution of lipofuscin within 
the retinal pigment epithelium. Accumulation of 
lipofuscin within retinal pigment epithelial cells 
is known to be involved in the pathogenesis of 
age-related macular degeneration. Fundus autofluo-
rescence imaging is a useful technique to identify 
high-risk characteristics in patients with dry AMD. 
It also gives some valuable knowledge and clues in 
differential diagnosis of wet AMD.
MateriaL and Methods
Fifty patients (93 eyes) were examined with a Spec-
tralis HRA + OCT (Heidelberg Engineering, Germa-
ny). OCT examination was performed in order to 
confirm that the participants were suffering from GA. 
In OCT imaging, there was not any hyper-reflective 
band that could be attributed to scarring from previ-
ous choroidal neovascularisation in any patient. All 
the participants were thoroughly examined with a slit 
lamp and funduscopically by Dr Mallias. Best cor-
rected visual acuity (BCVA) was measured and multi-
colour and fundus autofluorescence imaging with the 
Spectralis HRA + OCT were obtained, in order to 
compare which imaging setting offers the most valua-
ble information and assesses progression of the disease 
for patients who suffer from GA. The mean age of the 
participants was 80 years, and their mean BCVA was 
20/40 in the Snellen visual acuity chart. 
resuLts
The comparison between the two methods was 
made empirically. Dr Mallias and his team assessed 
all the cases of the patients enrolled, trying to eval-
uate which module provides more useful informa-
tion in everyday practice. Below we present several 
cases of patients with GA in at least one eye, and 
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Figure 1. The right eye of the first patient
Figure 2. The left eye of the first patient
we compare multicolour imaging and fundus auto-
fluorescence imaging in their ability to estimate the 
extent of the retinal damage from GA. These cases 
were chosen as the most interesting ones, regarding 
the comparison between the two modalities.
patient 1
Female, 91 years old, diagnosed with dry AMD 
on both eyes. Her BCVA was 20/50 on both eyes 
(Fig. 1 and 2).
This patient of GA had foveal spearing. Mul-
ticolour imaging shows a  central area of the ret-
ina, close to the fovea, with no atrophy despite 
the extensive retinal atrophy surrounding this area. 
The foveal sparing could not be depicted by the 
autofluorescence imaging. For this particular pa-
tient, multicolour imaging was superior to fundus 
autofluorescence in imaging the central retinal area, 
which was not affected by GA.
patient 2
Male, 80 years old, with dry AMD on both 
eyes. His BCVA was 20/25 on the right eye and 
20/32 on the left eye (Fig. 3 and 4). 
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Figure 3. Images of the right eye of the second patient, captured with autofluorescence (a) and multicolour module (B). In both imaging mo-
dalities, a paracentral area of retinal atrophy can be seen. The extent of the retinal atrophy appears to be the same in both imaging modalities. 
From the fundus autofluorescence image, the fact that the retinal atrophy has not yet reached the foveal vascular zone is better depicted
Figure 4. The left eye of the second patient. Multicolour imaging (a) shows a circular paracentral area with greyish colour, which re-
flects an area of retinal pigment epithelium abnormalities. This area in depicted in both green and blue reflectance but not in infrared (B). 
Also, this area is not depicted with fundus autofluorescence (C and d)
a B
C d
a B
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Figure 5. The right eye of the third patient
Figure 6. The left eye of the third patient
patient 3
Female, 82 years old, diagnosed with dry AMD 
on both eyes. Her BCVA was 20/30 on both eyes 
(Figs. 5 and 6).
This patient did not have GA, but had dry 
AMD with reticular pseudodrusen in the parafove-
al area and hard drusen at the foveal centre. Retic-
ular pseudodrusen are better depicted with fundus 
autofluorescence. Hard drusen at the foveal centre 
are depicted with dark orange colour in multicol-
our imaging.
patient 4
Female, 86 years old, with dry AMD on both 
eyes. Her BCVA was 20/30 on her right eye and 
20/200 on her left (Fig. 7 and 8).
patient 5
Female, 83 years old, diagnosed with dry AMD 
on both of her eyes. Her BCVA was 20/100 on the 
right eye and 20/40 on the left eye (Fig. 9 and 10).
In this patient, both imaging modalities showed 
the paracentral area of retinal atrophy from GA. 
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Figure 7. The right eye of the fourth patient. There is an extensive area of retinal atrophy with foveal sparing, and this is why the visual 
acuity remains quite good. Again, foveal sparing was better depicted with multicolour imaging than fundus autofluorescence
Figure 8. The left eye of the fourth patient. Although the area of retinal atrophy was smaller compared to the right eye, visual acuity was 
worse because foveal photoreceptors were already damaged by the disease. The lesions peripherally to the area of retinal atrophy were 
better depicted with fundus autofluorescence compared to multicolour imaging
The visual acuity of the right eye was much worse 
compared to the visual acuity of the left eye. With 
fundus Autofluorescence observed that there were 
already lesions from the disease, affecting the fove-
al avascular zone (FAZ), compared to the left eye 
where no lesions of the FAZ were observed with 
fundus autofluorescence. Despite the fact that this 
was a  case of foveal sparing, FAF was superior to 
multicolour imaging for this particular case.
disCussion
It is known that, unfortunately, there is no current 
treatment for GA. However, there was a study [18] 
(Spectri) from Roche (Switzerland) on the use of 
a substance called lampalizumab, which was inves-
tigated to determine its effect on the progression of 
geographic atrophy associated with advanced dry 
AMD. Unfortunately, Roche officially stopped the 
study due to poor results compared to the “placebo” 
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Figure 9. The right eye of the fifth patient
Figure 10. The left eye of the fifth patient
group. The company now is waiting for the results 
of an identically designed study (Chroma), which 
will be announced in November 2017. 
Another solution that can give some function 
back to patients with geographic atrophy are: Schar-
ioth Macula Lens [19, 20] and Implantable Minia-
ture Telescope [21, 22] for macular degeneration. 
A  Scharioth Macula Lens is an intraocular lens 
placed on the sulcus and it has a central addition 
of +10 dioptres, on a diameter of 12 mm. This lens 
helps patients with severe dry AMD to read through 
the central addition because it offers a magnification 
two times the size of the original image. The lens 
is placed on the dominant eye, or in cases where 
the visual acuity is very poor, the lens is placed on 
the eye with the best visual acuity. In order to pro-
ceed with the implantation of the Scharioth Macula 
Lens, the patient should already be operated for 
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cataract in the imminent eye, and the intraocular 
lens should be placed on the capsular bag. In order 
for a patient to be happy with the outcome of the 
Scharioth Macula Lens, he/she should understand 
and accept that the reading distance that the lens 
can offer is 15 cm. The Scharioth Macula Lens does 
not affect distant vision.
The implantable miniature telescope (IMT) 
takes advantage of the fact that even in severe dry 
AMD, when geographic atrophy and scarring oc-
curs, the peripheral retina is usually not affected. 
Thereby, it enlarges objects in the centre of the 
visual field so they can be seen by the intact parts of 
the retina around the macula. The IMT involves pa-
tients with corrected vision of 20/160–20/800. An 
IMT is implanted instead of the standard plastic 
intraocular lens, so the patient should not have 
undergone cataract surgery beforehand. There are 
two models of IMT available: one with 2.2-times 
magnification and the other with 2.7-times magni-
fication. This higher magnification version provides 
better visual acuity but slightly smaller visual field 
(20 vs. 24 degrees). IMT causes a decrease in depth 
perception, but this can improve with learning and 
experience over time. 
From the images of the patients presented, it is 
obvious that multicolour imaging provides a better 
image of foveal sparing in GA. However, there were 
cases (such as patient 5) where the lesions progressed 
closer to the fovea. In these cases, FAF modality 
provides a  better image and gives an explanation 
for the diminished visual acuity. Concluding, as far 
as multicolour imaging and FAF are concerned in 
the monitoring of GA, there cannot be a clear se-
lection. Both modalities provide useful information 
and should both be performed in order to obtain as 
much information as possible.
The comparison of the two methods in all the 
patients was made empirically, as has already been 
reported. The reason for this is that in everyday 
practice it is not easy to take the time to actually 
measure and evaluate all the information that es-
pecially FAF has to offer (such as the depth and 
width of the atrophy). The goal of this paper was 
to show that it is possible to evaluate the severity 
of the GA of a patient when he/she first arrives at 
the practice by performing these two easy and fast 
examinations. Of course, if it is a returning patient 
who has been examined in the practice previously, 
the depth and width of the atrophy should be 
measured in order to accurately evaluate the dis-
ease progression. 
There are several studies that compare FAF to 
fundus cameras [23–26], confocal scanning laser 
ophthalmoscope [23–25] (cSLO), and spectral- 
-domain optical coherence tomography [27, 28] 
(sd-OCT) as well as studies comparing multicolour 
imaging to fundus photography [29], but to our 
knowledge there has been no study comparing FAF 
to multicolour imaging.
As medicine and technology develop rapidly, it 
would not be surprising if in the following years, 
one of the substances that is being tested by nu-
merous companies has an active effect on GA. Un-
til then, technology offers ophthalmologists and 
low-vision aid practitioners many tools in order to 
improve the quality of life of patients with GA. 
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